{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:59:53Z","timestamp":1700319593187},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1038\/nm0498-394","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T02:00:51Z","timestamp":1092880851000},"page":"394-395","source":"Crossref","is-referenced-by-count":8,"title":["Monster plaques: What they tell us about Alzheimer's disease"],"prefix":"10.1038","volume":"4","author":[{"given":"Bruce A.","family":"Yankner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0498394_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington, R. et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 375, 754\u2013760 (1995).","journal-title":"Nature"},{"key":"BFnm0498394_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269,973\u2013977(1995).","journal-title":"Science"},{"key":"BFnm0498394_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/00001756-199704140-00043","volume":"8","author":"JB Kwok","year":"1997","unstructured":"Kwok, J.B. et al. Two novel (M233T and R278T) pre-senilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8, 1537\u20131542 (1997).","journal-title":"Neuroreport"},{"key":"BFnm0498394_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm0498-452","volume":"4","author":"R Crook","year":"1998","unstructured":"Crook, R. et al. A variant of Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452\u2013455 (1998).","journal-title":"Nature Med."},{"key":"BFnm0498394_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.8191290","volume":"264","author":"N Suzuki","year":"1994","unstructured":"Suzuki, N. et al. An increased percentage of long amyloid \u03b2 protein secreted by familial amyloid \u03b2 protein precursor (\u03b2APP717) mutants. Science 264, 1336\u20131340(1994).","journal-title":"Science"},{"key":"BFnm0498394_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner, D. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin-1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2,864\u2013870 (1996).","journal-title":"Nature Med."},{"key":"BFnm0498394_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/383710a0","volume":"383","author":"K Duff","year":"1996","unstructured":"Duff, K. et al. Increased amyloid-\u03b242(43) in brains of mice expressing presenilin 1. Nature 383, 710\u2013713 (1996).","journal-title":"Nature"},{"key":"BFnm0498394_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt, D.R. et al. Familial Alzheimer's disease-linked presenilin-1 variants elevate A\u03b21-42\/1-40 ratio in vitro and in vivo. Neuron 17, 1005\u20131013 (1996).","journal-title":"Neuron"},{"key":"BFnm0498394_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3, 67\u201372 (1997).","journal-title":"Nature Med."},{"key":"BFnm0498394_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett, J.T. & Lansbury, P.T. Seeding \u2018one-dimensional crystallization\u2019 of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73,1055\u20131058(1993).","journal-title":"Cell"},{"key":"BFnm0498394_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","volume":"16","author":"BA Yankner","year":"1996","unstructured":"Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron  16, 921\u2013932 (1996).","journal-title":"Neuron"},{"key":"BFnm0498394_CR12","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"CJ Pike","year":"1993","unstructured":"Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C. Neurodegeneration induced by \u03b2-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13,1676\u20131687 (1993).","journal-title":"J. Neurosci."},{"key":"BFnm0498394_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0006-8993(93)90295-X","volume":"621","author":"MP Mattson","year":"1993","unstructured":"Mattson, M.P., Tomaselli, K.J. & Rydel, R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FCF. Brain Res. 621,35\u201349 (1993).","journal-title":"Brain Res."},{"key":"BFnm0498394_CR14","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxi-city requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. USA 91, 12243\u201312247(1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0498394_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410430124","volume":"43","author":"D Nochlin","year":"1998","unstructured":"Nochlin, D., Bird, T.D., Nemens, E.J., Ball, M.J & Sumi, S.M. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141). Ann. Neurol. 43, 131\u2013135 (1998).","journal-title":"Ann. Neurol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0498-394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0498-394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0498-394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:21:25Z","timestamp":1684448485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0498-394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["BFnm0498394"],"URL":"https:\/\/doi.org\/10.1038\/nm0498-394","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}